Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 2
2002 4
2003 8
2004 11
2005 10
2006 6
2007 2
2008 10
2009 9
2010 6
2011 2
2012 1
2014 1
2015 3
2016 2
2017 4
2018 1
2019 1
2021 1
2022 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Small-molecule inhibition of TNF-alpha.
He MM, Smith AS, Oslob JD, Flanagan WM, Braisted AC, Whitty A, Cancilla MT, Wang J, Lugovskoy AA, Yoburn JC, Fung AD, Farrington G, Eldredge JK, Day ES, Cruz LA, Cachero TG, Miller SK, Friedman JE, Choong IC, Cunningham BC. He MM, et al. Science. 2005 Nov 11;310(5750):1022-5. doi: 10.1126/science.1116304. Science. 2005. PMID: 16284179
Fragment-based drug discovery.
Erlanson DA, McDowell RS, O'Brien T. Erlanson DA, et al. J Med Chem. 2004 Jul 1;47(14):3463-82. doi: 10.1021/jm040031v. J Med Chem. 2004. PMID: 15214773 Review. No abstract available.
Site-directed ligand discovery.
Erlanson DA, Braisted AC, Raphael DR, Randal M, Stroud RM, Gordon EM, Wells JA. Erlanson DA, et al. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72. doi: 10.1073/pnas.97.17.9367. Proc Natl Acad Sci U S A. 2000. PMID: 10944209 Free PMC article.
Tethering: fragment-based drug discovery.
Erlanson DA, Wells JA, Braisted AC. Erlanson DA, et al. Annu Rev Biophys Biomol Struct. 2004;33:199-223. doi: 10.1146/annurev.biophys.33.110502.140409. Annu Rev Biophys Biomol Struct. 2004. PMID: 15139811 Review.
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM. Ravandi F, et al. Lancet Oncol. 2015 Sep;16(9):1025-1036. doi: 10.1016/S1470-2045(15)00201-6. Epub 2015 Jul 30. Lancet Oncol. 2015. PMID: 26234174 Free PMC article. Clinical Trial.
Nerve growth factor: structure and function.
Wiesmann C, de Vos AM. Wiesmann C, et al. Cell Mol Life Sci. 2001 May;58(5-6):748-59. doi: 10.1007/pl00000898. Cell Mol Life Sci. 2001. PMID: 11437236 Free PMC article. Review.
Searching for new allosteric sites in enzymes.
Hardy JA, Wells JA. Hardy JA, et al. Curr Opin Struct Biol. 2004 Dec;14(6):706-15. doi: 10.1016/j.sbi.2004.10.009. Curr Opin Struct Biol. 2004. PMID: 15582395 Review.
Fragment-based lead discovery: a chemical update.
Erlanson DA. Erlanson DA. Curr Opin Biotechnol. 2006 Dec;17(6):643-52. doi: 10.1016/j.copbio.2006.10.007. Epub 2006 Nov 3. Curr Opin Biotechnol. 2006. PMID: 17084612 Review.
84 results